Advancing Precision in Respiratory Research

Expedited Study Start-Up: Your Fast Lane to Breakthroughs

Leverage our ready-to-deploy respiratory team, pre-qualified sites, and existing infrastructure to reduce your study’s start-up period significantly. We can accelerate your first 60-90 days, moving faster than a typical cycle and providing a unique opportunity for rapid deployment of your upcoming respiratory studies.

Deep Therapeutic Expertise Across Complex Indications

Our dedicated respiratory team brings extensive experience across a broad spectrum of conditions, ready to tackle both established and emerging indications:

• Interstitial Lung Disease (ILD)
• Idiopathic Pulmonary Fibrosis (IPF)
• Asthma
• Eosinophilic Asthma
• Cystic Fibrosis
• COPD-Adjacent Endpoints
• Bronchiectasis
• Cough
• Additional Emerging Respiratory Areas

Patient-Centric Approach & Sponsor Satisfaction

We conduct qualitative interviews with patients and caregivers to gain a deep understanding of their motivations and needs, ensuring that we design our trials with the patient experience as a top priority. Our sponsors consistently report high satisfaction with our responsiveness, attention to detail, and the overall quality of our respiratory delivery teams.

Industry-Leading Endpoint Quality & Data Reliability

Our commitment to exceptional data quality sets us apart, and we understand the nuances of pulmonary function testing. We ensure superior pulmonary function data through:

Rigorous Training 

• Our CRAs and medical experts provide purpose-built training to sites, ensuring accurate and reproducible respiratory endpoints, even in non-specialized settings.

Guideline Adherence

• Our spirometry execution consistently meets and exceeds industry benchmarks, with a 94% acceptable rate compared with the 91% industry average, aligned with and exceeding ATS/ERS 2019 standards.

Strategic Partnership with Clario 

• Our integrated partnership enhances equipment quality, data review, and ongoing site proficiency, strengthening endpoint reliability.

Proactive Monitoring

• We meticulously monitor data for outliers, ensuring the integrity and quality of every endpoint.

Global Reach with Proven Site Networks

Benefit from our established network of over 100 high-performing sites across North America, Latin America, Europe, and Asia-Pacific. These relationships deliver robust patient recruitment and consistently high-quality data, ensuring the global success of your study.